Introduction: The COVID-19 pandemic has had a major impact on health care. Shifts in inpatient and outpatient case numbers and morbidity have been quantified in other medical specialties (e.g., oncology and psychiatry). Such an analysis is lacking in neurological cases. Thus, we performed an anonymized, retrospective, multicenter analysis of administrative data from a network of 86 hospitals in Germany. Methods: Over 350,000 neurological cases admitted between January 2019 and December 2022 were included. The main outcome measures were (1) deficit in inpatient hospital admissions during the pandemic compared to changes in outpatient cases; (2) morbidity, mortality, and complication rates during the pandemic; and (3) length of stay for inpatients. Results: There was an evident deficit in inpatient admissions between −11% and −20%, which was not compensated for by outpatient cases. Furthermore, hospitalized patients exhibited several significantly increased measures of mortality (3.7% vs. 3.2%, p < 0.001) and morbidity compared to the pre-pandemic period. Interestingly, the proportion of patients with specific chronic comorbidities at risk for severe COVID-19, such as congestive heart failure, was lower during the pandemic (10% vs. 12%, p < 0.001). Finally, the length of hospital stay was shorter during the pandemic (i.e., 6.5 vs. 6.4 days during the wildtype period, p < 0.001). Conclusion: These findings suggest a significant shift in hospital utilization patterns among neurology departments during the COVID-19 pandemic. While overall admissions decreased, average case severity was significantly higher. The latter was due to a selection bias because elective cases, less urgent and less morbid patients avoided hospital admission, or because their admission may have been delayed. A shorter length of stay was indicative of more efficient treatment. The avoidance of hospital care by patients with severe comorbidities could indicate a changed prioritization and utilization pattern but could also point to unmet health care needs. These observations underline the necessity for healthcare systems to adapt resource allocation and patient management strategies to ensure continuous quality of care during a pandemic.

1.
Carroll
WD
,
Strenger
V
,
Eber
E
,
Porcaro
F
,
Cutrera
R
,
Fitzgerald
DA
, et al
.
European and United Kingdom COVID-19 pandemic experience: the same but different
.
Paediatr Respir Rev
.
2020
;
35
:
50
6
.
2.
Ueberham
L
,
König
S
,
Pellissier
V
,
Hohenstein
S
,
Meier-Hellmann
A
,
Kuhlen
R
, et al
.
Admission rates and care pathways in patients with atrial fibrillation during the COVID-19 pandemic: insights from the German-wide Helios hospital network
.
Eur Heart J Qual Care Clin Outcomes
.
2021
;
7
(
3
):
257
64
.
3.
Bollmann
A
,
Hohenstein
S
,
Pellissier
V
,
Stengler
K
,
Reichardt
P
,
Ritz
JP
, et al
.
Utilization of in- and outpatient hospital care in Germany during the Covid-19 pandemic insights from the German-wide Helios hospital network
.
PLoS One
.
2021
;
16
(
3
):
e0249251
.
4.
König
S
,
Hohenstein
S
,
Pellissier
V
,
Leiner
J
,
Hindricks
G
,
Nachtigall
I
, et al
.
Changing trends of patient characteristics and treatment pathways during the COVID-19 pandemic: a cross-sectional analysis of 72,459 inpatient cases from the German Helios database
.
Front Public Health
.
2022
;
10
:
1028062
.
5.
Dengler
J
,
Prass
K
,
Palm
F
,
Hohenstein
S
,
Pellisier
V
,
Stoffel
M
, et al
.
Changes in nationwide in-hospital stroke care during the first four waves of COVID-19 in Germany
.
Eur Stroke J
.
2022
;
7
(
2
):
166
74
.
6.
Elixhauser
A
,
Steiner
C
,
Harris
DR
,
Coffey
RM
.
Comorbidity measures for use with administrative data
.
Med Care
.
1998
;
36
(
1
):
8
27
.
7.
Moore
BJ
,
White
S
,
Washington
R
,
Coenen
N
,
Elixhauser
A
.
Identifying increased risk of readmission and in-hospital mortality using hospital administrative data: the AHRQ Elixhauser Comorbidity Index
.
Med Care
.
2017
;
55
(
7
):
698
705
.
8.
Gasparini
A
.
Comorbidity: an R package for computing comorbidity scores
.
J Open Source Softw
.
2018
;
3
(
23
):
648
.
9.
Baayen
RH
,
Davidson
DJ
,
Bates
DM
.
Mixed-effects modeling with crossed random effects for subjects and items
.
J Mem Lang
.
2008
;
59
(
4
):
390
412
.
10.
Bates
D
,
Mächler
M
,
Bolker
BM
,
Walker
SC
.
Fitting linear mixed-effects models using lme4
.
J Stat Softw
.
2015
;
67
(
1
):
1
48
.
11.
R Core Team
.
R: a language and environment for statistical computing
[cited 2020 Jan 1]. Available from: https://www.R-project.org/
12.
Rod
JE
,
Oviedo-Trespalacios
O
,
Cortes-Ramirez
J
.
A brief-review of the risk factors for covid-19 severity
.
Rev Saude Publica
.
2020
;
54
:
60
.
13.
Dengler
J
,
Gheewala
H
,
Kraft
CN
,
Hegewald
AA
,
Dörre
R
,
Heese
O
, et al
.
Changes in frailty among patients hospitalized for spine pathologies during the COVID-19 pandemic in Germany: a nationwide observational study
.
Eur Spine J
.
2024
;
33
(
1
):
19
30
.
14.
Sabbatini
AK
,
Robicsek
A
,
Chiu
S-T
,
Gluckman
TJ
.
Excess mortality among patients hospitalized during the COVID-19 pandemic
.
J Hosp Med
.
2021
;
16
(
10
):
596
602
.
15.
Tal-Ben Ishay
R
,
Faierstein
K
,
Mayan
H
,
Shilo
N
.
Comparison of the mortality of non-COVID hospitalized patients during the COVID pandemic: a retrospective cohort study in a tertiary medical center in Israel
.
Isr Med Assoc J
.
2023
;
25
(
10
):
655
61
.
16.
Specogna
AV
,
Turin
TC
,
Patten
SB
,
Hill
MD
.
Hospital treatment costs and length of stay associated with hypertension and multimorbidity after hemorrhagic stroke
.
BMC Neurol
.
2017
;
17
(
1
):
158
8
.
17.
Funk
MJ
,
Landi
SN
.
Misclassification in administrative claims data: quantifying the impact on treatment effect estimates
.
Curr Epidemiol Rep
.
2014
;
1
(
4
):
175
85
.
18.
Manuel
DG
,
Rosella
LC
,
Stukel
TA
.
Importance of accurately identifying disease in studies using electronic health records
.
BMJ
.
2010
;
341
:
c4226
.
19.
Riedel-Heller
S
,
Bramesfeld
A
,
Roick
C
,
Becker
T
,
König
H-H
.
Der Ruf nach mehr Versorgungsforschung
.
Psychiatr Prax
.
2008
;
35
(
4
):
157
9
.
20.
Cozad
M
,
Lindley
LC
,
Eaker
C
,
Carlosh
KA
,
Profant
TL
.
Debunking myths about health insurance claims data for public health research and practice
.
Am J Public Health
.
2019
;
109
(
11
):
1584
5
.
21.
World Medical Association
.
World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects
.
JAMA
.
2013
;
310
(
20
):
2191
4
.
You do not currently have access to this content.